These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5864716)

  • 1. Biopharmaceutical studies on factors affecting rate of absorption of drugs. I. Absorption of salicylamide in micellar solution.
    Yamada H; Yamamoto R
    Chem Pharm Bull (Tokyo); 1965 Nov; 13(11):1279-84. PubMed ID: 5864716
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carbonated beverages and of an antiemetic containing carbohydrate and phosphoric acid on riboflavin bioavailability and salicylamide biotransformation in humans.
    Houston JB; Levy G
    J Pharm Sci; 1975 Sep; 64(9):1504-7. PubMed ID: 1185567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the rate of dissolution and absorption of salicylamide from tablet and suspension dosage forms.
    Bates TR; Lambert DA; Johns WH
    J Pharm Sci; 1969 Dec; 58(12):1468-70. PubMed ID: 5353261
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the thermodynamics of dissolution, solubilization and micellar binding of salicylamide by a nonionic surfactant.
    Biber MZ; Rhodes CT
    Acta Pharm Suec; 1974 Jun; 11(3):275-82. PubMed ID: 4839737
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of complex formation on drug absorption. IX. Determination of the intestinal transfer rate constant of the salicylamide-caffeine complex.
    Reuning RH; Levy G
    J Pharm Sci; 1969 Jan; 58(1):79-83. PubMed ID: 5765843
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-related differences in salicylamide and acetaminophen conjugation in man.
    Alam SN; Roberts RJ; Fischer LJ
    J Pediatr; 1977 Jan; 90(1):130-5. PubMed ID: 830879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pyrogen-induced fever on salicylamide metabolism in man.
    Song CS; Gelb NA; Wolff SM
    J Clin Invest; 1972 Nov; 51(11):2959-66. PubMed ID: 5080420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical studies on factors affecting rate of absorption of drugs. II. Further investigation of absorption of drugs in micellar solution.
    Yamada H; Ichihashi T; Kogishi F; Yamamoto R
    Chem Pharm Bull (Tokyo); 1966 Jul; 14(7):786-8. PubMed ID: 5967156
    [No Abstract]   [Full Text] [Related]  

  • 9. Sodium salicylamide: relative bioavailability and subjective effects.
    Fleckenstein L; Mundy GR; Horovitz RA; Mazzullo JM
    Clin Pharmacol Ther; 1976 Apr; 19(4):451-8. PubMed ID: 1269196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in hepatic uptake kinetics of aspirin and salicylamide in rats.
    Iwamoto K; Furune Y; Watanabe J
    Biochem Pharmacol; 1984 Oct; 33(19):3089-95. PubMed ID: 6487359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal first-pass metabolism of phenacetin, acetaminophen, ethenzamide and salicylamide in rabbits pretreated with 3,4-benzo[a]pyrene.
    Nakamura J; Nakamura T; Podder SK; Sasaki H; Shibasaki J
    Biochem Pharmacol; 1987 Apr; 36(7):1171-4. PubMed ID: 3566811
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors influencing absorption and excretion of drugs. IV. Effect of hypertonic and hypotonic solutions on in situ rat intestinal absorption of several drugs.
    Kojima S; Miyake J
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1247-55. PubMed ID: 1182873
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple-dose pharmacokinetics of paracetamol and salicylamide in man after combined rectal application (author's transl)].
    Liedtke R; Ebel S; Missler B; Haase W; Stein L
    Arzneimittelforschung; 1980; 30(8):1295-8. PubMed ID: 7192145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effect of sulfur nutrition on the metabolism of salicylamide.
    Kurzynske JS; Smith JT
    Drug Nutr Interact; 1982; 1(2):169-75. PubMed ID: 6926825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism and central nervous system distribution of C-14 carbonyl salicylamide in the rat.
    BOUSQUET WF; CHRISTIAN JE
    J Am Pharm Assoc Am Pharm Assoc; 1960 Jun; 49():389-93. PubMed ID: 13849144
    [No Abstract]   [Full Text] [Related]  

  • 16. The excretion and tissue distribution of C14-carbonyl salicylamide in the rat.
    BOUSQUET WF; CHRISTIAN JE
    J Am Pharm Assoc Am Pharm Assoc; 1958 Aug; 47(8):542-4. PubMed ID: 13563265
    [No Abstract]   [Full Text] [Related]  

  • 17. "Salicyluria"--the ingestion of salicylamide.
    Stevens HM
    Med Sci Law; 1965 Jul; 5(3):157-8. PubMed ID: 5828804
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary metabolites of salicylamide in stone-formers.
    FOYE WO; DUVALL RN; LANGE WE; TALBOT MH; PRIEN EL
    J Pharmacol Exp Ther; 1959 Mar; 125(3):198-201. PubMed ID: 13642257
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Bacterial degradation of salicylamide.
    Grant DJ; Burgess SM; Rambow EJ; Yelling PW
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():49P. PubMed ID: 2723
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression of salicylamide glucuronidation by bacterial lipopolysaccharide.
    Kushiya M; Hasegawa R; Komuro T; Isaka H
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):416-20. PubMed ID: 3594667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.